About Anatomic Pathology Testing The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases. Technavio’s analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.... Research Beam Model: Research Beam Product ID: 1237653 3500 USD New
Global Anatomic Pathology Testing Market 2017-2021
 
 

Global Anatomic Pathology Testing Market 2017-2021

  • Category : Healthcare
  • Published On : February   2017
  • Pages : 95
  • Publisher : Technavio
 
 
 
About Anatomic Pathology Testing

The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.

Technavio’s analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific

Other prominent vendors
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Agendia
• Angsana Molecular & Diagnostics Laboratory
• AutoGenomics
• Biocare Medical
• Biocartis
• CellMax Life
• Cancer Genetics
• Digipath
• Enzo Biochem
• Epic Sciences
• Janssen Diagnostic
• Monogram Biosciences
• Nucleix
• Omnyx
• Oxford Cancer Biomarkers
• RareCyte
• SAKURA FINETEK USA
• Tecan
• VolitionRx

Market driver
• Growing prevalence of cancer in demographics
• For a full, detailed list, view our report

Market challenge
• High initial investment and maintenance costs
• For a full, detailed list, view our report

Market trend
• Presence of venture capitalists in market
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by products
• Instruments and imaging systems
• Consumables and accessories
PART 07: Market segmentation by application
• Breast cancer
• Lung cancer
• Colorectal cancer
• Lymphoma
• Cervical cancer
• Prostate cancer
• Other diseases
PART 08: Market segmentation by end-user
• Hospitals
• Clinical diagnostic laboratories
• Physicians€™ office laboratories
PART 09: Geographical segmentation
• Anatomic pathology testing market in Americas
• Anatomic pathology testing market in EMEA
• Anatomic pathology testing market in APAC
PART 10: Market drivers
• Growing prevalence of cancer in demographics
• Use of biomarkers for disease diagnosis and increasing efficiency
• Paradigm shift toward precision diagnosis through personalized medicine
PART 11: Impact of drivers
PART 12: Market challenges
• Insurance coverage and reimbursement issues
• Limitations of closed systems
• High initial investment and maintenance cost
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Presence of venture capitalists in market
• Ready-to-use reagents
• Business strategies to increase market competitiveness
PART 15: Vendor landscape
• Competitive landscape analysis
PART 16: Key vendor analysis
• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Methods used in anatomic pathology testing
Exhibit 03: Use of digital pathology testing
Exhibit 04: Global anatomic pathology testing market 2016-2021 ($ millions)
Exhibit 05: Product dynamic analysis of instruments and reagents in 2016 and 2021
Exhibit 06: Five forces analysis
Exhibit 07: Global anatomic pathology testing market by products in 2016 and 2021 ($ billions)
Exhibit 08: Market overview: Instruments and imaging systems
Exhibit 09: Anatomic pathology testing market by instruments and imaging systems 2016-2021 ($ billions)
Exhibit 10: Market overview: Consumables and accessories
Exhibit 11: Anatomic pathology testing market by consumables and accessories 2016-2021 ($millions)
Exhibit 12: Global anatomic pathology testing market by application in 2016
Exhibit 13: Global anatomic pathology testing market by end-users in 2015
Exhibit 14: Strategies, benefits and challenges of clinical diagnostic laboratories to remain competitive
Exhibit 15: Global anatomic pathology testing market by geography in 2016 and 2021 ($billions)
Exhibit 16: Market overview: Anatomic pathology testing market in Americas
Exhibit 17: Anatomic pathology testing market in Americas 2016-2021 ($ billions)
Exhibit 18: Key takeaway: Anatomic pathology testing market in US
Exhibit 19: PEST analysis: Anatomic pathology testing market in UK
Exhibit 20: Market overview: Anatomic pathology testing market in EMEA
Exhibit 21: Anatomic pathology testing market in EMEA 2016-2021 ($billions)
Exhibit 22: Key takeaway: Anatomic pathology testing market in UK
Exhibit 23: PEST analysis: Anatomic pathology testing market in UK
Exhibit 24: Market overview: Anatomic pathology testing market in APAC
Exhibit 25: Anatomic pathology testing market in APAC 2016-2021 ($billions)
Exhibit 26: Key takeaway: Anatomic pathology testing market in China
Exhibit 27: PEST analysis: Anatomic pathology testing market in China
Exhibit 28: People in age group 60 years and above worldwide 2010-2050
Exhibit 29: Companies and laboratories focusing on biomarkers
Exhibit 30: Companies focusing on companion diagnostic and personalized medicine
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: Partnership between companies and venture capitalists
Exhibit 34: Business strategies by companies to remain competitive in market
Exhibit 35: Competitive structure analysis of global anatomic pathology testing market 2015
Exhibit 36: Competitive analysis of global anatomic pathology testing market 2016
Exhibit 37: Abbott Diagnostics: Strength assessment
Exhibit 38: Abbott Diagnostics: Strategy assessment
Exhibit 39: Abbott Diagnostics: Opportunity assessment
Exhibit 40: Agilent Technologies: Strength assessment
Exhibit 41: Agilent Technologies: Strategy assessment
Exhibit 42: Agilent Technologies: Opportunity assessment
Exhibit 43: Danaher: Strength assessment
Exhibit 44: Danaher: Strategy assessment
Exhibit 45: Danaher: Opportunity assessment
Exhibit 46: Roche Diagnostics: Strength assessment
Exhibit 47: Roche Diagnostics: Strategy assessment
Exhibit 48: Roche Diagnostics: Opportunity assessment
Exhibit 49: Thermo Fisher Scientific: Strength assessment
Exhibit 50: Thermo Fisher Scientific: Strategy assessment
Exhibit 51: Thermo Fisher Scientific: Opportunity assessment
Exhibit 52: Other prominent vendors

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT